Faculty of Education, Health and Wellbeing, University of Wolverhampton, UK; Department of Rheumatology, Russells Hall Hospital, Dudley Group NHS Foundation Trust, Dudley, UK; School of Physical Education and Sport Science, University of Thessaly, Greece.
Department of Rheumatology, Russells Hall Hospital, Dudley Group NHS Foundation Trust, Dudley, UK; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, UK.
Best Pract Res Clin Rheumatol. 2018 Oct;32(5):669-682. doi: 10.1016/j.berh.2019.03.013. Epub 2019 Apr 17.
Rheumatoid arthritis (RA) is characterised by functional disability, pain, fatigue and body composition alterations that can further impact on the physical dysfunction seen in RA. RA is also associated with systemic manifestations, most notably an increased risk for cardiovascular disease. There is strong evidence to suggest that increasing physical activity and/or exercise can simultaneously improve symptoms and reduce the impact of systemic manifestations in RA. However, implementation of interventions to facilitate increased physical activity and/or exercise within routine clinical practice is slow because of not only patient-specific and healthcare professional-related barriers but also lack of relevant infrastructure and provision. We review the evidence supporting the physiological adaptations and beneficial effects occurring as a result of increased physical activity and/or exercise in RA and propose an implementation model for facilitating the long-term engagement of patients with RA. We propose that implementation should be led, in a pragmatic manner, by rheumatology healthcare practitioners and supported by social innovation.
类风湿关节炎(RA)的特征是功能障碍、疼痛、疲劳和身体成分改变,这可能进一步影响 RA 患者的身体功能障碍。RA 还与全身表现有关,最显著的是心血管疾病风险增加。有强有力的证据表明,增加身体活动和/或运动可以同时改善症状,并减轻 RA 全身表现的影响。然而,由于不仅存在患者特定和医疗保健专业人员相关的障碍,还缺乏相关的基础设施和供应,因此在常规临床实践中实施促进身体活动和/或运动的干预措施进展缓慢。我们回顾了支持 RA 患者增加身体活动和/或运动所带来的生理适应和有益效果的证据,并提出了促进 RA 患者长期参与的实施模型。我们提出,实施应以务实的方式,由风湿病学医疗保健从业者领导,并得到社会创新的支持。
Best Pract Res Clin Rheumatol. 2019-4-17
Eur J Phys Rehabil Med. 2016-12-19
Lakartidningen. 2004-11-4
Expert Rev Clin Immunol. 2015
Curr Opin Rheumatol. 2020-5
Int J Mol Sci. 2025-3-16
Front Med (Lausanne). 2025-1-15
Nat Rev Rheumatol. 2025-2